Rheumatoid arthritis develops when your immune system mistakenly attacks the lining of your joints, but the reason it starts doing this involves a chain of events rather than a single cause. About 18 million people worldwide live with the condition, and roughly 70% of them are women. The typical onset occurs in the sixties, though it can appear decades earlier. What triggers the immune system to turn on your own tissue comes down to a combination of genetic vulnerability, environmental exposures, hormonal shifts, and changes in your gut bacteria.
The Genetic Setup
Your genes don’t cause rheumatoid arthritis on their own, but they load the gun. The single most significant genetic risk factor is a set of gene variants called the “shared epitope,” found in a gene called HLA-DRB1. This gene helps your immune system distinguish between your own tissue and foreign invaders. In people who carry these variants, the immune system is more likely to misidentify certain modified proteins in the body as threats.
Not everyone with these gene variants develops rheumatoid arthritis, which is why researchers describe it as susceptibility rather than destiny. But carrying two copies of the shared epitope (one from each parent) raises your risk more than carrying one, creating a dose effect. The genetic link is especially strong in people who develop a specific type of autoantibody, which plays a central role in how the disease actually unfolds.
How the Immune System Goes Wrong
The core problem in rheumatoid arthritis involves your body producing antibodies against its own proteins, specifically proteins that have undergone a chemical change called citrullination. Citrullination is a normal biological process where one building block in a protein gets swapped for a slightly different one. In most people, the immune system ignores these modified proteins. In people with genetic susceptibility, the immune system treats them as foreign and produces antibodies to attack them.
These antibodies, known as anti-citrullinated protein antibodies (ACPA), are the earliest detectable sign that something is going wrong. They can appear in the blood years before any joint symptoms show up. One study found ACPA present a median of 4.5 years before diagnosis, with some cases showing positivity as far back as 13 years. Another found RA-related autoantibodies circulating up to 20 years before clinical disease. This long, silent buildup is called the pre-clinical phase: your immune system is already reacting, but your joints feel fine.
Once these antibodies reach the joints, they trigger inflammation in the synovial lining, the thin membrane that cushions and lubricates the joint. Over time, this inflammation thickens the lining, damages cartilage, and erodes bone.
Smoking and Lung Exposure
Smoking is the strongest and most well-established environmental trigger for rheumatoid arthritis. The connection isn’t just statistical; there’s a clear biological chain linking cigarette smoke to the autoimmune process. Smoking increases the production of an enzyme called PAD2 in both the deep lung tissue and the airway lining. This enzyme drives citrullination, the same protein modification the immune system reacts against. Researchers have confirmed that citrullinated proteins are significantly more abundant in the lung fluid of smokers compared to nonsmokers.
In someone who carries the shared epitope gene variants, this is a dangerous combination. The genes make the immune system prone to reacting against citrullinated proteins, and smoking floods the lungs with exactly those proteins. The lungs may actually be the place where rheumatoid arthritis begins, long before it reaches the joints.
Other inhaled exposures carry similar risks. Occupational exposure to silica dust, common in mining, construction, and even household cleaning products, is associated with a 2.59-fold higher odds of developing the disease.
Why Women Are Affected More
Women under 50 develop rheumatoid arthritis at four to five times the rate of men the same age. That gap narrows after menopause but doesn’t disappear: between ages 60 and 70, women are still affected at twice the rate of men. The pattern strongly suggests that sex hormones play a protective or destabilizing role.
Estrogen and progesterone appear to suppress the autoimmune activity behind the disease. During pregnancy, when both hormones surge, many women with existing rheumatoid arthritis experience temporary remission. After delivery, when hormone levels plummet, the disease often flares. Menopause creates a similar shift: the sustained drop in estrogen and progesterone that comes with it coincides with the peak age of onset. Breastfeeding, which maintains altered hormone levels, also appears to be protective.
Gut Bacteria and Gum Disease
Your microbiome, the collection of bacteria living in your gut and mouth, plays a surprisingly direct role in whether rheumatoid arthritis develops. Research from the National Institutes of Health found that 75% of people with new-onset, untreated rheumatoid arthritis had a gut bacterium called Prevotella copri, compared to just 21% of healthy controls. Higher levels of this bacterium correlated with reductions in several groups of beneficial microbes, suggesting the gut ecosystem shifts before the disease takes hold.
The mouth matters too. A bacterium involved in gum disease, Porphyromonas gingivalis, is the only known microorganism that produces its own citrullination enzyme. It can generate citrullinated proteins directly in inflamed gum tissue. A meta-analysis found that exposure to this bacterium increases the risk of rheumatoid arthritis by 86%. The proposed sequence is that citrullinated proteins produced by this oral bacterium break immune tolerance at the gum line, and then the immune reaction spreads to target similar proteins throughout the body, eventually reaching the joints.
How Inflammation Changes Your Cells
Once the inflammatory process gets going, it doesn’t just damage tissue directly. It also reprograms the cells lining your joints in ways that make the disease self-sustaining. Inflammatory signals reduce the activity of enzymes that control how genes are switched on and off, a process called epigenetic modification. In lab studies, exposing joint-lining cells to inflammatory molecules for as little as two hours began altering how genes were expressed, and sustained exposure over 14 days produced lasting changes that mimicked the patterns seen in rheumatoid arthritis patients.
This helps explain why rheumatoid arthritis is a chronic condition. Even if the original trigger disappears, the joint-lining cells have been epigenetically “imprinted” by the inflammatory environment. They continue behaving aggressively, producing inflammatory signals and contributing to joint destruction on their own. It also explains why people without obvious genetic risk factors can still develop the disease: environmental exposures and chronic inflammation can alter gene activity independently of inherited DNA.
The Chain of Events
Rheumatoid arthritis doesn’t happen all at once. It unfolds over years in a sequence that researchers now understand fairly well. First, genetic susceptibility sets the stage. Then an environmental exposure, whether smoking, silica dust, gut bacteria, or gum disease, triggers the production of citrullinated proteins. The immune system begins producing antibodies against those proteins, often years before any symptoms appear. Hormonal shifts, particularly drops in estrogen, can accelerate or unmask this process. Eventually, the autoimmune reaction reaches the joints, causing the inflammation, swelling, and pain that lead to a diagnosis.
No single factor is enough on its own. Most people who smoke never get rheumatoid arthritis. Most people with the shared epitope gene variants never get it either. But when multiple risk factors converge in the same person, the probability rises substantially. This layered model also explains why the disease can look so different from person to person: the specific combination of genetic, environmental, hormonal, and microbial factors varies, producing different patterns of severity and progression.